JurisdictionCaliforniaCode HSCHealth and Safety Code - HSC
Div. 107.DIVISION 107. HEALTH CARE ACCESS AND INFORMATION
Part 2.PART 2. HEALTH POLICY AND PLANNING
Ch. 2.5.CHAPTER 2.5. Fair Pricing Policies
Art. 3.ARTICLE 3. Prescription Drug Pricing for Covered Entities
This text of California § 127471. (127471. (Added by Stats. 2023, Ch. 414, Sec. 1.)) is published on Counsel Stack Legal Research, covering California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
(a)A pharmacy benefit manager shall not impose any requirements, conditions, or exclusions that do either of the following:
(1)Discriminate against a covered entity or a specified pharmacy in connection with dispensing covered drugs.
(2)Prevent a covered entity from retaining the benefit of discounted pricing for the purchase of covered drugs.
(b)Discrimination prohibited
pursuant to subdivision (a) includes, but is not limited to, all of the following:
(1)Payment terms, reimbursement methodologies, or other terms and conditions that distinguish between covered drugs and other drugs, account for the availability of discounts under the 340B discount drug purchasing program described in Section 256b of Title 42 of the United States Code in determining reimbursement, or are less Free access — add to your briefcase to read the full text and ask questions with AI
(a)
A pharmacy benefit manager shall not impose any requirements, conditions, or exclusions that do either of the following:
(1)
Discriminate against a covered entity or a specified pharmacy in connection with dispensing covered drugs.
(2)
Prevent a covered entity from retaining the benefit of discounted pricing for the purchase of covered drugs.
(b)
Discrimination prohibited
pursuant to subdivision (a) includes, but is not limited to, all of the following:
(1)
Payment terms, reimbursement methodologies, or other terms and conditions that distinguish between covered drugs and other drugs, account for the availability of discounts under the 340B discount drug purchasing program described in Section 256b of Title 42 of the United States Code in determining reimbursement, or are less favorable than the payment terms or reimbursement methodologies for similarly situated entities that are not furnishing or dispensing covered drugs.
(2)
Terms or conditions applied to covered entities or specified pharmacies based on the furnishing or dispensing of covered drugs or their status as a covered entity or specified pharmacy, including restrictions or
requirements for participation in specialty, standard, or preferred pharmacy networks, or requirements related to the frequency or scope of audits.
(3)
Refusing to contract with or terminating a contract with a covered entity or specified pharmacy, or otherwise excluding a covered entity or specified pharmacy from a
specialty, standard or preferred network, on the basis that the entity or pharmacy is a covered entity or a specified pharmacy or for reasons other than those that apply equally to entities or pharmacies that are not covered entities or specified pharmacies.
(4)
Retaliation against a covered entity or specified pharmacy based on its exercise of any right or remedy under this article.
(5)
Interfering with an individual’s choice to receive a covered drug from a covered entity or specified pharmacy, whether in person or via direct delivery, mail, or other form of shipment.
(6)
Restricting or prohibiting a covered entity from raising a grievance or speaking publicly about any pharmacy benefit manager that violates this subdivision or from filing a legal action against a
pharmacy benefit manager for violating this subdivision.
(c)
This section does not apply to the Medi-Cal program or the federal Medicare Program but does apply to pharmacy benefit managers that contract with managed care organizations that serve Medi-Cal or Medicare members.
(d)
The provisions of this section shall not be waived, voided, or nullified by contract.
(e)
This article shall only be implemented to the extent that it is consistent with Section 256b of Title 42 of the United States Code or any rules or regulations adopted thereunder.